doi: 10.1001/jamainternmed.2014.4854.
Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012
Affiliations
- PMID: 25127107
- DOI: 10.1001/jamainternmed.2014.4854
Item in Clipboard
Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012
JAMA Intern Med.
2014 Oct.
No abstract available
Similar articles
-
Marketing off-label uses to physicians: FDA's draft (mis)guidance.Am J Bioeth. 2008 Mar;8(3):1-3. doi: 10.1080/15265160802116624. Am J Bioeth. 2008. PMID: 18570084 No abstract available.
-
Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety Withdrawals.Drug Saf. 2017 Jun;40(6):497-503. doi: 10.1007/s40264-017-0526-1. Drug Saf. 2017. PMID: 28342075 Free PMC article.
-
PLIVA v. Mensing: generic consumers' unfortunate hand.Yale J Health Policy Law Ethics. 2012 Summer;12(2):209-63. Yale J Health Policy Law Ethics. 2012. PMID: 23175916 No abstract available.
-
An analysis of legal warnings after drug approval in Thailand.Regul Toxicol Pharmacol. 2015 Feb;71(1):108-13. doi: 10.1016/j.yrtph.2014.10.013. Epub 2014 Oct 27. Regul Toxicol Pharmacol. 2015. PMID: 25445000 Review.
-
Preventing postmarketing changes in recommended doses and marketing withdrawals.Ernst Schering Res Found Workshop. 2007;(59):209-16. doi: 10.1007/978-3-540-49529-1_16. Ernst Schering Res Found Workshop. 2007. PMID: 17117726 Review.
Cited by
-
New and incremental FDA black box warnings from 2008 to 2015.Expert Opin Drug Saf. 2018 Feb;17(2):117-123. doi: 10.1080/14740338.2018.1415323. Epub 2017 Dec 17. Expert Opin Drug Saf. 2018. PMID: 29215916 Free PMC article.
-
Recognition and Knowledge of Medications with Black Box Warnings Among Pediatricians and Emergency Physicians.J Med Toxicol. 2016 Jun;12(2):180-4. doi: 10.1007/s13181-015-0519-3. J Med Toxicol. 2016. PMID: 26553279 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
